Building on discoveries from the Lencer Lab, our technology harnesses a natural process of cellular transport. With it, we can achieve greater degrees of bioavailability and biodistribution without disruption to the body’s natural barriers.
We are actively seeking partners to develop biologic medicines for a range of chronic diseases, including metabolic, autoimmune, and neurological disorders. Our interests include peptide, protein, and oligonucleotide therapeutics.